Skip to search.
 FTSE 100 Down 0.33%

Becton, Dickinson and Company (BDX)

-NYSE
165.53 Up 0.91(0.55%) 2 Dec 21:01
|After Hours: : 165.53 0.00 (0.00%) 2 Dec 21:34
Prev Close:164.62
Open:165.49
Bid:161.88 x 100
Ask:172.27 x 200
1y Target Est:188.57
Beta:0.998153
Earnings Date:1 Feb - 6 Feb (Est.)
Day's Range:164.75 - 167.32
52wk Range:129.50 - 181.76
Volume:909,819
Avg Vol (3m):1,052,400
Market Cap:35.15b
P/E (ttm):36.87
EPS (ttm):4.49
Div & Yield:2.92 (1.76%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for BDX at this time.

Comparison

Symbol% ChgMkt Cap
BDXUp 0.55%35.15b
BAXUp 0.87%23.94b
ABTUp 0.80%55.80b

Key Statistics

Forward P/E (1 yr):15.75
P/S (ttm):2.80
Ex-Dividend Date:07-Dec-16

Analysts

Annual EPS Est (Sep-17) :9.52
Quarterly EPS Est (Dec-16) :2.12
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.66

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback